These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32472048)

  • 1. Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.
    He F; Yang J; Zhang X; Yu W
    Sci Rep; 2020 May; 10(1):8778. PubMed ID: 32472048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study.
    He F; Yu W
    Eye (Lond); 2020 Aug; 34(8):1413-1418. PubMed ID: 31719675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
    Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis.
    Wang L; Chen Z; Wang X
    Medicine (Baltimore); 2021 Apr; 100(17):e25611. PubMed ID: 33907112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
    Yang CS; Hung KC; Huang YM; Hsu WM
    J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy.
    Zhang Q; Zhang T; Zhuang H; Sun Z; Qin Y
    Ophthalmologica; 2019; 242(2):59-68. PubMed ID: 30699427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observation of retinal neovascularization using optical coherence tomography angiography after panretinal photocoagulation for proliferative diabetic retinopathy.
    Feng HE; Weihong YU; Dong F
    BMC Ophthalmol; 2021 Jun; 21(1):252. PubMed ID: 34098891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
    Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
    Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study.
    Lang GE; Stahl A; Voegeler J; Quiering C; Zaremba L; Lorenz K; Spital G; Liakopoulos S
    Acta Ophthalmol; 2022 Mar; 100(2):e578-e587. PubMed ID: 34121335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.
    Zhou AY; Zhou CJ; Yao J; Quan YL; Ren BC; Wang JM
    Int J Ophthalmol; 2016; 9(12):1772-1778. PubMed ID: 28003978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy.
    Shin YW; Lee YJ; Lee BR; Cho HY
    Korean J Ophthalmol; 2009 Dec; 23(4):266-72. PubMed ID: 20046686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
    Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.
    Zhang W; Zhao G; Fan W; Zhao T
    BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study.
    Si M; Tao Y; Zhang Z; Zhao H; Cui W; Yang M; Wang H
    Front Endocrinol (Lausanne); 2023; 14():1218442. PubMed ID: 37693359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.
    Zhang X; Wu C; Zhou LJ; Dai RP
    Sci Rep; 2018 Mar; 8(1):3972. PubMed ID: 29507304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).
    Tonello M; Costa RA; Almeida FP; Barbosa JC; Scott IU; Jorge R
    Acta Ophthalmol; 2008 Jun; 86(4):385-9. PubMed ID: 17995982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
    Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
    Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
    Messias K; Barroso RM; Jorge R; Messias A
    Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.
    Messias A; Ramos Filho JA; Messias K; Almeida FP; Costa RA; Scott IU; Gekeler F; Jorge R
    Doc Ophthalmol; 2012 Jun; 124(3):225-36. PubMed ID: 22457045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.